ARCHIVES

New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science

This article is from The Cancer Letter archive.

Vol. 25 No. 01 | January 8, 1999

Download PDF Visit The Full Archive

Related Articles

Flood Says Congress Will Renew Cancer Act, But Only After “All Out” Review of Research Policy

December 3, 1976

Also in this 8-page issue: Bush nominates McClellan to head CMS.

February 27, 2004

NCI Human Tissue Network Resources Available For Research

January 24, 1997

Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months

September 26, 2014

FDA Urges Lower Target for ESA Use; Market Could Drop By More Than Half.

March 16, 2007

Obama’s Virtual Colonoscopy Sets Off Real-World Turf War Of Specialty Groups.

March 5, 2010